ADT-Related Fracture Boosts Mortality Risk

Share this content:

Men with prostate cancer receiving androgen deprivation therapy who experience a fracture may have a 1.38-fold higher mortality risk. John Schieszer has the story in today's Medical Minute.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters